Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia

Published:2019-12-16 Issue:1 Volume:4 Page:e312
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Schumich Angela,Prchal-Murphy Michaela,Maurer-Granofszky Margarita,Hoelbl-Kovacic Andrea,Mühlegger Nora,Pötschger Ulrike,Fajmann Sabine,Haas Oskar A.,Nebral Karin,von Neuhoff Nils,Zimmermann Martin,Boztug Heidrun,Rasche Mareike,Dolezal Marlies,Walter Christiane,Reinhardt Dirk,Sexl Veronika,Dworzak Michael N.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference50 articles.

1. Development of treatment and clinical results in childhood AML in Austria (1993–2013);Boztug;Memo.,2014

2. Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012;Rasche;Leukemia.,2018

3. Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia;Kornblau;Blood.,2006

4. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation;Stone;N Engl J Med.,2017

5. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial;Rollig;Lancet Oncol.,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia;Haematologica;2022-12-15

2. Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia;Current Drug Targets;2021-11

3. Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways;International Journal of Molecular Sciences;2021-07-15

4. Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia;Clinical and Translational Oncology;2021-05-04

5. Cell signaling pathways as molecular targets to eliminate AML stem cells;Critical Reviews in Oncology/Hematology;2021-04